PUBLISHER: Acute Market Reports | PRODUCT CODE: 1453014
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1453014
Anti-Radiation Drugs Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
The anti-radiation drugs market is expected to grow at a CAGR of 10.1% during the forecast period of 2024 to 2032, driven by the increasing prevalence of radiation exposure and the demand for effective therapeutic interventions. While distribution challenges present a notable constraint, the market's dynamic nature is evident in the distinct roles of compounds and applications. As North America leads in revenue and Asia-Pacific emerges as a growth hub, strategic initiatives by key players underscore the collaborative efforts shaping the market's trajectory. The imperative for overcoming distribution challenges and advancing therapeutic applications positions the anti-radiation drugs market on a path of continuous evolution and innovation.
Key Market Drivers
Potassium Iodide (KI) Driving Market Growth
Potassium Iodide (KI) stands as a pivotal driver in the anti-radiation drugs market. With its well-established role in thyroid protection during radiation emergencies, KI has witnessed increased adoption worldwide. Evidence supporting this driver includes the widespread distribution of KI tablets by government agencies for public use in the event of nuclear accidents. For instance, the U.S. Nuclear Regulatory Commission recommends the use of KI as a thyroid-blocking agent during radiological emergencies, underscoring its significance in radiation protection.
Expanding Applications in Cancer Treatment
The expanding applications of anti-radiation drugs in cancer treatment contribute significantly to market growth. Prussian Blue, known for its efficacy in treating internal contamination with radioactive cesium and thallium, exemplifies this driver. The evidence lies in the clinical use of Prussian Blue to enhance the elimination of radioactive isotopes in patients, minimizing radiation exposure and improving therapeutic outcomes. The adoption of anti-radiation drugs as adjuncts to cancer therapy reflects their evolving role beyond emergency situations.
Increasing Preparedness for Nuclear Events
The global increase in preparedness for nuclear events acts as a key driver for the anti-radiation drugs market. Diethylenetriamine Pentaacetate (DTPA) and other chelating agents play a crucial role in treating individuals exposed to radioactive materials. The evidence supporting this driver includes the inclusion of DTPA in emergency response plans and medical countermeasures to address radiological incidents. Governments and healthcare institutions worldwide are actively enhancing their capabilities to respond to nuclear emergencies, fostering the demand for anti-radiation drugs.
Restraint
Challenges in Distribution Channels
A significant restraint in the anti-radiation drugs market is associated with challenges in distribution channels. Despite the critical nature of these drugs, their availability in various distribution channels poses logistical challenges. Evidence supporting this constraint includes the limited accessibility of anti-radiation drugs in retail pharmacies and other outlets, hindering swift access for individuals in need. Overcoming these distribution challenges is crucial to ensuring timely and widespread availability during radiation emergencies.
Market Segmentation Analysis
Market by Compound: Potassium Iodide (KI) Dominates the Market
In 2023, Potassium Iodide (KI) emerged as the revenue leader, driven by its widespread use in radiation emergencies. Simultaneously, DTPA exhibited the highest CAGR, underscoring its increasing adoption for treating individuals exposed to radioactive materials. The evidence lies in the distinct roles these compounds play - KI for thyroid protection and DTPA for chelation therapy, demonstrating the market's dynamic nature and diverse applications.
Market by Application: ARS Dominates the Market
The market segmentation by application showcased ARS as the revenue leader in 2023, emphasizing the crucial role of anti-radiation drugs in addressing acute radiation effects. However, the Cancer Treatment segment exhibited the highest CAGR, indicating the growing utilization of these drugs in therapeutic settings. The evidence supporting this lies in clinical studies and advancements in cancer treatment protocols that incorporate anti-radiation drugs.
Market by Distribution Channel: Hospital Pharmacies Dominate the Market
Hospital Pharmacies led in both revenue and CAGR in 2023, emphasizing the pivotal role of healthcare institutions in dispensing anti-radiation drugs. The evidence lies in the specialized nature of these drugs, requiring expert guidance and oversight. Retail Pharmacies, while contributing to accessibility, exhibited a lower CAGR, reflecting the challenges in distributing specialized medications through traditional retail channels.
North America Remains the Global Leader
North America emerged as the region with the highest revenue and CAGR in 2023, driven by robust preparedness initiatives and a well-established regulatory framework. The evidence supporting this includes government programs for distributing KI tablets and enhancing medical countermeasures. Asia-Pacific showcased substantial growth potential, with a focus on improving nuclear emergency response capabilities and increasing awareness of anti-radiation drugs.
Market Competition to Intensify during the Forecast Period
In 2023, top players such as Recipharm AB, NukeRx, Bausch Health Companies Inc, Amgen Inc., Anbex Inc., Arco Pharmaceuticals LLC, BTG International Inc., Cellphire, Inc., Chrysalis BioTherapeutics, Inc., Darnitsa, Enzychem Lifesciences Corporation, Humanetics Corporation, Mission Pharmacal Company, Myelo Therapeutics GmbH, Partner Therapeutics, and Pluri Inc. played pivotal roles in the anti-radiation drugs market. Their key strategies encompassed partnerships, regulatory approvals, and advancements in drug formulations. Recipharm's collaboration with Cumberland Pharmaceuticals for the manufacturing and commercialization of Ethyol reflects the strategic alliances shaping the market. NukeRx's focus on developing innovative radiation countermeasures and Bausch Health's commitment to expanding their radiation-related product portfolio contribute to the competitive dynamics.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Anti-Radiation Drugs market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report
Micro and macro environment factors that are currently influencing the Anti-Radiation Drugs market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Compound
- Potassium Iodide (KI)
- Prussian Blue
- DTPA (Diethylenetriamine Pentaacetate)
- Others
Application
- Acute Radiation Syndrome (ARS)
- Cancer Treatment
- Radiation Exposure
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
Region Segment (2021-2031; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Anti-Radiation Drugs market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2031.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Anti-Radiation Drugs market?
Which is the largest regional market for Anti-Radiation Drugs market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Anti-Radiation Drugs market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Anti-Radiation Drugs market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Anti-Radiation Drugs Market
- 2.2. Global Anti-Radiation Drugs Market, By Compound, 2023 (US$ Million)
- 2.3. Global Anti-Radiation Drugs Market, By Application, 2023 (US$ Million)
- 2.4. Global Anti-Radiation Drugs Market, By Distribution Channel, 2023 (US$ Million)
- 2.5. Global Anti-Radiation Drugs Market, By Geography, 2023 (US$ Million)
- 2.6. Attractive Investment Proposition by Geography, 2023
3. Anti-Radiation Drugs Market: Competitive Analysis
- 3.1. Market Positioning of Key Anti-Radiation Drugs Market Vendors
- 3.2. Strategies Adopted by Anti-Radiation Drugs Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2023 Versus 2032
4. Anti-Radiation Drugs Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Anti-Radiation Drugs Market Value, 2022 - 2032, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
- 4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
- 4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape
5. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2023 Versus 2032
- 5.3. Market Segmentation
- 5.3.1. Potassium Iodide (KI)
- 5.3.2. Prussian Blue
- 5.3.3. DTPA (Diethylenetriamine Pentaacetate)
- 5.3.4. Others
6. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2023 Versus 2032
- 6.3. Market Segmentation
- 6.3.1. Acute Radiation Syndrome (ARS)
- 6.3.2. Cancer Treatment
- 6.3.3. Radiation Exposure
- 6.3.4. Others
7. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2023 Versus 2032
- 7.3. Market Segmentation
- 7.3.1. Hospital Pharmacies
- 7.3.2. Retail Pharmacies
- 7.3.3. Others
8. North America Anti-Radiation Drugs Market, 2022-2032, USD (Million)
- 8.1. Market Overview
- 8.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 8.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 8.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 8.5.Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
- 8.5.1.North America
- 8.5.1.1. U.S.
- 8.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 8.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 8.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 8.5.1.2. Canada
- 8.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 8.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 8.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 8.5.1.3. Rest of North America
- 8.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 8.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 8.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 8.5.1.1. U.S.
- 8.5.1.North America
9. UK and European Union Anti-Radiation Drugs Market, 2022-2032, USD (Million)
- 9.1. Market Overview
- 9.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 9.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 9.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 9.5.Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
- 9.5.1.UK and European Union
- 9.5.1.1. UK
- 9.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 9.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 9.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 9.5.1.2. Germany
- 9.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 9.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 9.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 9.5.1.3. Spain
- 9.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 9.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 9.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 9.5.1.4. Italy
- 9.5.1.4.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 9.5.1.4.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 9.5.1.4.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 9.5.1.5. France
- 9.5.1.5.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 9.5.1.5.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 9.5.1.5.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 9.5.1.6. Rest of Europe
- 9.5.1.6.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 9.5.1.6.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 9.5.1.6.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 9.5.1.1. UK
- 9.5.1.UK and European Union
10. Asia Pacific Anti-Radiation Drugs Market, 2022-2032, USD (Million)
- 10.1. Market Overview
- 10.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 10.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 10.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 10.5.Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
- 10.5.1.Asia Pacific
- 10.5.1.1. China
- 10.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 10.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 10.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 10.5.1.2. Japan
- 10.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 10.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 10.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 10.5.1.3. India
- 10.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 10.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 10.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 10.5.1.4. Australia
- 10.5.1.4.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 10.5.1.4.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 10.5.1.4.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 10.5.1.5. South Korea
- 10.5.1.5.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 10.5.1.5.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 10.5.1.5.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 10.5.1.6. Rest of Asia Pacific
- 10.5.1.6.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 10.5.1.6.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 10.5.1.6.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 10.5.1.1. China
- 10.5.1.Asia Pacific
11. Latin America Anti-Radiation Drugs Market, 2022-2032, USD (Million)
- 11.1. Market Overview
- 11.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 11.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 11.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 11.5.Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
- 11.5.1.Latin America
- 11.5.1.1. Brazil
- 11.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 11.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 11.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 11.5.1.2. Mexico
- 11.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 11.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 11.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 11.5.1.3. Rest of Latin America
- 11.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 11.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 11.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 11.5.1.1. Brazil
- 11.5.1.Latin America
12. Middle East and Africa Anti-Radiation Drugs Market, 2022-2032, USD (Million)
- 12.1. Market Overview
- 12.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 12.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 12.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 12.5.Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
- 12.5.1.Middle East and Africa
- 12.5.1.1. GCC
- 12.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 12.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 12.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 12.5.1.2. Africa
- 12.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 12.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 12.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 12.5.1.3. Rest of Middle East and Africa
- 12.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
- 12.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
- 12.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 12.5.1.1. GCC
- 12.5.1.Middle East and Africa
13. Company Profile
- 13.1. Recipharm AB
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
- 13.2. NukeRx
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
- 13.3. Bausch Health Companies Inc
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
- 13.4. Amgen Inc.
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
- 13.5. Anbex Inc.
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
- 13.6. Arco Pharmaceuticals LLC
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
- 13.7. BTG International Inc.
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
- 13.8. Cellphire, Inc.
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
- 13.9. Chrysalis BioTherapeutics, Inc.
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
- 13.10. Darnitsa
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
- 13.11. Enzychem Lifesciences Corporation
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
- 13.12. Humanetics Corporation
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives
- 13.13. Mission Pharmacal Company
- 13.13.1. Company Overview
- 13.13.2. Financial Performance
- 13.13.3. Product Portfolio
- 13.13.4. Strategic Initiatives
- 13.14. Myelo Therapeutics GmbH
- 13.14.1. Company Overview
- 13.14.2. Financial Performance
- 13.14.3. Product Portfolio
- 13.14.4. Strategic Initiatives
- 13.15. Partner Therapeutics
- 13.15.1. Company Overview
- 13.15.2. Financial Performance
- 13.15.3. Product Portfolio
- 13.15.4. Strategic Initiatives
- 13.16. Pluri Inc.
- 13.16.1. Company Overview
- 13.16.2. Financial Performance
- 13.16.3. Product Portfolio
- 13.16.4. Strategic Initiatives
- 13.17. Other Notable Players
- 13.17.1. Company Overview
- 13.17.2. Financial Performance
- 13.17.3. Product Portfolio
- 13.17.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 2 Global Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 3 Global Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 4 North America Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 5 North America Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 6 North America Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 7 U.S. Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 8 U.S. Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 9 U.S. Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 10 Canada Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 11 Canada Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 12 Canada Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 13 Rest of North America Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 14 Rest of North America Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 15 Rest of North America Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 16 UK and European Union Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 17 UK and European Union Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 18 UK and European Union Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 19 UK Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 20 UK Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 21 UK Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 22 Germany Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 23 Germany Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 24 Germany Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 25 Spain Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 26 Spain Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 27 Spain Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 28 Italy Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 29 Italy Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 30 Italy Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 31 France Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 32 France Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 33 France Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 34 Rest of Europe Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 35 Rest of Europe Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 36 Rest of Europe Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 37 Asia Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 38 Asia Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 39 Asia Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 40 China Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 41 China Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 42 China Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 43 Japan Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 44 Japan Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 45 Japan Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 46 India Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 47 India Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 48 India Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 49 Australia Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 50 Australia Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 51 Australia Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 52 South Korea Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 53 South Korea Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 54 South Korea Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 55 Latin America Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 56 Latin America Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 57 Latin America Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 58 Brazil Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 59 Brazil Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 60 Brazil Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 61 Mexico Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 62 Mexico Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 63 Mexico Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 64 Rest of Latin America Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 65 Rest of Latin America Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 66 Rest of Latin America Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 67 Middle East and Africa Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 68 Middle East and Africa Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 69 Middle East and Africa Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 70 GCC Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 71 GCC Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 72 GCC Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 73 Africa Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 74 Africa Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 75 Africa Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 76 Rest of Middle East and Africa Anti-Radiation Drugs Market By Compound, 2022-2032, USD (Million)
- TABLE 77 Rest of Middle East and Africa Anti-Radiation Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 78 Rest of Middle East and Africa Anti-Radiation Drugs Market By Distribution Channel, 2022-2032, USD (Million)
List of Figures
- FIG. 1 Global Anti-Radiation Drugs Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Anti-Radiation Drugs Market: Quality Assurance
- FIG. 5 Global Anti-Radiation Drugs Market, By Compound, 2023
- FIG. 6 Global Anti-Radiation Drugs Market, By Application, 2023
- FIG. 7 Global Anti-Radiation Drugs Market, By Distribution Channel, 2023
- FIG. 8 Global Anti-Radiation Drugs Market, By Geography, 2023
- FIG. 9 Market Geographical Opportunity Matrix - Global Anti-Radiation Drugs Market, 2023
FIG. 10Market Positioning of Key Anti-Radiation Drugs Market Players, 2023
FIG. 11Global Anti-Radiation Drugs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
- FIG. 12 Global Anti-Radiation Drugs Market, By Compound, 2023 Vs 2032, %
- FIG. 13 Global Anti-Radiation Drugs Market, By Application, 2023 Vs 2032, %
- FIG. 14 Global Anti-Radiation Drugs Market, By Distribution Channel, 2023 Vs 2032, %
- FIG. 15 U.S. Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 16 Canada Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 17 Rest of North America Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 18 UK Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 19 Germany Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 20 Spain Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 21 Italy Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 22 France Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 23 Rest of Europe Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 24 China Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 25 Japan Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 26 India Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 27 Australia Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 28 South Korea Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 29 Rest of Asia Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 30 Brazil Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 31 Mexico Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 32 Rest of Latin America Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 33 GCC Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 34 Africa Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
- FIG. 35 Rest of Middle East and Africa Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
